share_log

樂普生物-B:自願性公告 MRG003 用於治療復發性/ 轉移性鼻咽癌(R/M NPC) 完成關鍵註冊性IIb期臨床試驗受試者入組

LEPU BIO-B: VOLUNTARY ANNOUNCEMENT COMPLETION OF PATIENT ENROLLMENT OF PIVOTAL PHASE IIb CLINICAL TRIAL FOR MRG003 FOR THE TREATMENT OF R/M NPC

Hong Kong Stock Exchange ·  Dec 28, 2023 17:12
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more